Cooper Companies, Inc. (COO) Stock Price & Analysis
Cooper Companies, Inc. (COO) rose 0.11% to USD 70.31 as of July 25, 2026 at 01:43 UTC, according to Nexqual real-time market data.
COO last closed at USD 70.23; the session ranged USD 70.2–70.9 on volume of 1,389,406 shares. Market capitalization is —, with a 52-week range of USD 58.89–89.83 (NMS). Source: Nexqual, July 25, 2026 at 01:43 UTC.
Key Statistics (as of July 25, 2026 at 01:43 UTC)
| Price | USD 70.31 |
|---|---|
| Change | ▲ 0.11% (up) |
| Previous Close | USD 70.23 |
| Open | USD 70.61 |
| Day Range | USD 70.2 – 70.9 |
| 52-Week Range | USD 58.89 – 89.83 |
| Volume | 1,389,406 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (COO)
Nexqual's technical model rates COO "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:43 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.31 (neutral) |
| vs SMA50 | Above (USD 66.88) |
| MACD | 0.86 (positive) |
Analyst Ratings (COO)
Wall Street analysts rate COO "Buy" based on 13 analysts, with a mean price target of USD 81.69 (range USD 66–92), per Nexqual as of July 25, 2026 at 01:43 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 13 |
| Mean Target | USD 81.69 |
| High Target | USD 92 |
| Low Target | USD 66 |
| Buy / Hold / Sell | 10 / 5 / 0 |
Earnings (COO)
| Next Earnings Date | 2026-09-03 |
|---|---|
| EPS Estimate | USD 1.12 |
| Revenue Estimate | $1.10B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 1.21 vs est 1.09 ▲ beat |
| 2026-01-31 | USD 1.1 vs est 1.03 ▲ beat |
| 2025-10-31 | USD 1.15 vs est 1.11 ▲ beat |
| 2025-07-31 | USD 1.1 vs est 1.07 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:43 UTC.
Financials & Fundamentals (COO)
| Total Revenue | $4.23B |
|---|---|
| Revenue Growth (YoY) | +7.90% |
| Gross Margin | +65.55% |
| Operating Margin | -2.87% |
| Profit Margin | +5.57% |
| ROE | +2.85% |
| Debt / Equity | 33.09 |
| Current Ratio | 1.27 |
| Total Cash | $138.80M |
| Total Debt | $2.73B |
| Free Cash Flow | $424.28M |
Source: Nexqual, July 25, 2026 at 01:43 UTC.
Financial Health Score (COO)
Nexqual rates Cooper Companies, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:43 UTC.
| Growth | Solid — Revenue +8% YoY (latest Q) |
|---|---|
| Profitability | Solid — Gross margin 66%, operating -3% |
| Balance Sheet | Solid — $139M cash vs $2.73B debt |
| Cash Flow | Solid — FCF $424M, 10% margin |
| Efficiency | Weak — ROE 3%, ROA 2.5% |
Ownership (COO)
| Insider Ownership | +0.61% |
|---|---|
| Institutional Ownership | +106.81% |
| Float | 193.67M |
| Short % of Float | +4.34% |
Source: Nexqual, July 25, 2026 at 01:43 UTC.
Leadership (COO)
Cooper Companies, Inc. is led by Albert G. White (age 55), President, CEO & Non-Independent Director, per Nexqual as of July 25, 2026 at 01:43 UTC.
| President, CEO & Non-Independent Director | Albert G. White (age 55) |
|---|---|
| Executive VP, CFO, Treasurer & Principal Accounting Officer | Brian G. Andrews (age 46) |
| Executive VP, COO General Counsel & Secretary | Daniel G. McBride (age 61) |
| President of CooperSurgical, Inc. | Holly R. Sheffield (age 54) |
| President of CooperVision, Inc. | Gerard H. Warner (age 60) |
Major Backers & Investors (COO)
Notable institutional backers of Cooper Companies, Inc. include T. Rowe Price, Capital Group, Browning West Lp, according to Nexqual as of July 25, 2026 at 01:43 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 8.3% |
| Capital Group | 3.8% |
| Browning West Lp | 3.58% |
| Kayne Anderson Rudnick Investment Management LLC | 3.39% |
| Price (T.Rowe) Associates Inc | 2.77% |
| Invesco | 1.38% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.49% |
| BlackRock | 9.84% |
| State Street | 5.71% |
| Geode Capital | 2.72% |
Source: Nexqual, July 25, 2026 at 01:43 UTC.
From Cooper Companies, Inc.'s Latest SEC 10-K Filing (filed 2025-12-05)
Key Strengths & Strategy (as disclosed to the SEC)
- The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
- The company operates in two segments, CooperVision and CooperSurgical.
- The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
- Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TFX | Teleflex Incorporated | USD 132.1 | ▼ 2% |
| MTD | Mettler-Toledo International, I | USD 1,327.18 | ▲ 3.21% |
| STE | STERIS plc (Ireland) | USD 214.07 | ▲ 1.66% |
| XRAY | DENTSPLY SIRONA Inc. | USD 12.93 | ▼ 2.56% |
| RMD | ResMed Inc. | USD 195.27 | ▲ 1.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:43 UTC. This page is informational and not investment advice.